40
Participants
Start Date
July 31, 2009
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Ambrisentan
Ambrisentan (5 mg or 10 mg tablet) administered orally once daily.
Placebo
Placebo to match ambrisentan administered orally once daily.
Medizinische Universität Wien, Vienna
St. Vincents Hospital, Sydney
The Prince Charles Hospital, Chermside
Royal Perth Hospital, Perth
Medizinische Universität Graz, Graz
Mount Sinai School of Medicine, New York
Columbia University, New York
Centro delle Interstiziopatie Polmonari e Malattie Rare del Polmone, Torino
North Shore Health System, New Hyde Park
Winthrop University Hospital, Mineola
Albany Medical Center, Albany
Alleghany General Hospital, Pittsburgh
Evangelische Lungenklinik Berlin, Berlin
University of Pittsburgh Cancer Institute, Pittsburgh
Universitat Greifswald, Greifswald
Hospital of the University of Pennsylvania, Philadelphia
Temple University School of Medicine, Philadelphia
Unita Funzionale di Pneumologia e Fisiopatologia Respiratoria, Milan
Johns Hopkins University School of Medicine, Baltimore
Inova Heart Institiute and Vascular Institute, Falls Church
Virginia Commonwealth University Health System, Richmond
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Atlanta Institute for Medical Research, Decatur
Medizinische Hochschule Hannover, Hanover
University of Florida, Gainesville
University of Miami Medical Center, Miami
Cleveland Clinic Florida, Weston
Bay Area Chest Physicians, Clearwater
Suncoast Lung Center, Sarasota
Sarasota Memorial Hospital, Sarasota
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
Ohio State University, Columbus
University Hospitals of Cleveland Case Western, Cleveland
Cleveland Clinic Foundation, Cleveland
The Lindner Center for Research & Education at The Christ Hospital, Cincinnati
University of Michigan Health Systems, Ann Arbor
Azienda Ospedaliera Universitaria Senese, Siena
Mayo Clinic Rochester, Rochester
University of Chicago, Chicago
Washington University, St Louis
Thorax Klinik, Heidelberg
Creighton University Center for Allergy & Asthma, Omaha
University of Texas Southwestern, Dallas
Baylor College of Medicine, Houston
Universitatsklinikum Freiburg, Freiburg im Breisgau
University of Colorado Heatlh Sciences Center, Aurora
University of Utah, Salt Lake City
Mayo Clinic Arizona, Scottsdale
David Geffen School of Medicine UCLA, Los Angeles
University of California San Diego Medical Center, San Diego
Krankenhaus Donaustauf der LVA, Donaustauf
University of California at San Francisco, San Francisco
Stanford University, Stanford
University of California Davis, Davis
Providence Everett Medical Center, Everett
Kentuckiana Pulmonary Association, Louisville
Maine Medical Center, Portland
Medical University of South Carolina, Charleston
Universitatsklinikum Innsbruck, Innsbruck
Toronto General Hospital, Toronto
Sir Mortimer B. Davis Jewish General Center, Montreal
Charite-Universitatsmedizin Berlin, Berlin
LMU Klinikum der Universitat, München
Azienda Ospedaliero Universitaria, Catania
Presidio Ospedaliero G.B. Morgagni, Forlì
Ospedale S.Giuseppe Fatebenefratelli, Milan
Azienda Ospedaliera di Padova, Padua
Instituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo
Policlinico Universitario Tor Vergata, Rome
University Hospital Aintree, Liverpool
University College Hosptial, London
Royal Hallamshire Hospital, Sheffield
Tufts Medical Center, Boston
Brigham and Women's Hospital, Boston
Boston University Medical Center, Boston
Beth Israel Deacones Medical Center, Boston
Dartmouth Medical School, Lebanon
Peter Loughheed Center- Calgary General Hospital, Calgary
University of British Columbia, Vancouver
London Health Sciences Centre, London
Centre Hospitalier De L'Universite de Montreal, Montreal
Centre de Pneumologie de L'Hospital Laval, Sainte-Foy
Papworth Hospital NHS Foundation Trust, Cambridge
Lead Sponsor
Gilead Sciences
INDUSTRY